MS-EAE Efficacy Studies Tech Sheet
Read Flipbook
Read Flipbook
Read Flipbook
Read Flipbook
Ready to discuss your project needs?
Contact UsRead Flipbook
Read Flipbook
Read Flipbook
The Jackson Laboratory is the exclusive service provider for robust, reliable, reproducible gene therapy, efficacy, and safety studies in the C9orf72 mouse model, the most common form of familial ALS.
Read Flipbook
Our team of subject matter experts will design your new mouse model based on your research goals.
Read Flipbook
For over 90 years JAX has been helping researchers reliably and cost-effectively mitigate risk by preserving strains through our reproductive services.
Read Flipbook
Read Flipbook
Review JAX’s CRS evaluation capabilities and see how a CRS study can help move your CAR T therapeutic into the clinic faster, safer, and more confidently.
Read Flipbook
A glimpse at the wide range of platforms and services JAX offers to help move you from drug discovery to IND filing.
Read Flipbook
An example of study information provided when conducting a GvHD study with the Jackson Laboratory. This example shows Bispecific Antibodies in comparison with Abatacept.
Read Flipbook
Read Flipbook
Read Flipbook
Read Flipbook
Read Flipbook
This document highlights the key differences between aged and young C57BL/6J mice when it comes to NASH.
Read Flipbook
Metabolic phenotypes expected from the JAX MSNASH/PcoJ Model
Read Flipbook
Rob Taft, PhD, Senior Services Program Manager at The Jackson Laboratory (JAX) speaks with GEN about how to keep research resilient post-COVID-19.
Read Flipbook
Loading More...